
Overview
Jeffrey Port is a Thoracic Surgeon in New York, New York. Dr. Port is rated as an Advanced provider by MediFind in Lymphadenectomy. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Lung Nodules, Thymectomy, and Lymphadenectomy.
His clinical research consists of co-authoring 88 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Lymphadenectomy.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
Locations
525 E 68th St # M-404, New York, NY 10065
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Department Of Cardiovascular & Thoracic Surgery
Brendon Stiles, MD, is Professor and Chief, Thoracic Surgery and Surgical Oncology, Department of Cardiothoracic & Vascular Surgery at Montefiore Einstein, and the Associate Director for Surgical Services in the Montefiore Einstein Cancer Center. Dr. Stiles’ clinical focus is on the treatment of lung and esophageal cancer and unusual thoracic cancers including metastatic tumors and those invading the heart. He also has a clinical interest in treating benign chest and upper gastrointestinal diseases. Taking a patient-first philosophy, Dr. Stiles provides world-class personalized care, using minimally invasive, organ-sparing techniques and targeting surgical therapy to the specific needs of the patient and his or her individual tumor.“The recruitment of Dr. Stiles elevates the treatment of lung cancer to a historic level,” said Robert E. Michler, MD, Surgeon-in-Chief and Chairman and Professor, Department of Surgery and Department of Cardiothoracic & Vascular Surgery at Montefiore-Einstein. “Every thoracic surgical therapy available anywhere in the world will now be offered by Dr. Stiles at Montefiore-Einstein.”After earning his Bachelor of Arts in 1994 at the University of Virginia, Dr. Stiles continued at UVA, earning his Doctor of Medicine in 1999. He conducted his training in general surgery at the University of Virginia Health System. From 2001 to 2003, Dr. Stiles served as a surgical research fellow at Memorial Sloan-Kettering Cancer Center before returning to the University of Virginia Health System to complete his surgical residency. Dr. Stiles completed a cardiothoracic surgery residency at NewYork-Presbyterian Hospital-Weill Cornell and Memorial Sloan-Kettering Cancer Center in 2008. Dr. Stiles joined the faculty at NewYork-Presbyterian Hospital-Weill Cornell before being recruited by Dr. Michler to Montefiore-Einstein in 2021. Dr. Stiles is rated as a Distinguished provider by MediFind in Lymphadenectomy. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Esophageal Cancer, Lymphadenectomy, and Thymectomy.
Cardiothoracic Surgery At Weill Cornell Medical Center
Nasser Altorki is a Thoracic Surgeon in New York, New York. Dr. Altorki is rated as a Distinguished provider by MediFind in Lymphadenectomy. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Esophageal Cancer, Thymectomy, and Lymphadenectomy.
New York University
Sampath Kumar is a Vascular Surgeon and a General Surgeon in Brooklyn, New York. Dr. Kumar is rated as a Distinguished provider by MediFind in Lymphadenectomy. His top areas of expertise are Choledocholithiasis, Gallbladder Disease, Gallstones, Hernia Surgery, and Colostomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Port isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Esophageal CancerDr. Port isDistinguished. Learn about Esophageal Cancer.
- Lung CancerDr. Port isDistinguished. Learn about Lung Cancer.
- Lung NodulesDr. Port isDistinguished. Learn about Lung Nodules.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Port isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pleuropulmonary BlastomaDr. Port isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- EGFR Positive Lung CancerDr. Port isAdvanced. Learn about EGFR Positive Lung Cancer.
- Lung AdenocarcinomaDr. Port isAdvanced. Learn about Lung Adenocarcinoma.
- LymphadenectomyDr. Port isAdvanced. Learn about Lymphadenectomy.
- Metastatic Pleural TumorDr. Port isAdvanced. Learn about Metastatic Pleural Tumor.
- Neuroendocrine TumorDr. Port isAdvanced. Learn about Neuroendocrine Tumor.
- Stomach CancerDr. Port isAdvanced. Learn about Stomach Cancer.
- Experienced
- Aberrant Subclavian ArteryDr. Port isExperienced. Learn about Aberrant Subclavian Artery.
- Arterial EmbolismDr. Port isExperienced. Learn about Arterial Embolism.
- Bile Duct StrictureDr. Port isExperienced. Learn about Bile Duct Stricture.
- Collapsed LungDr. Port isExperienced. Learn about Collapsed Lung.
- Congenital Diaphragmatic HerniaDr. Port isExperienced. Learn about Congenital Diaphragmatic Hernia.
- EmphysemaDr. Port isExperienced. Learn about Emphysema.
